Certified Information Security Manager CISM Practice Test 12
Question 110
The SOC subscribed to more feeds but cannot demonstrate that intelligence actions reduced exposure or improved relevant detections. The committee needs evidence about threat intelligence applicability. Which deliverable would address the identified deficiency most directly?
- A traceable deployment record and operating test confirming action to prioritize relevant monitoring, patching and risk treatment for the operation needing effectiveness evidence.
- An assurance review and corrective-action record confirming results from a decision to measure whether intelligence-informed actions changed exposure or detection results for the operation needing effectiveness evidence.
- A signed delegation and escalation record authorizing the organization to assign threat-intelligence decisions to an owner of critical assets for the operation needing effectiveness evidence.
- A management-endorsed assessment documenting the evidence needed to check whether adversary tactics and prerequisites apply to local assets for the operation needing effectiveness evidence.
Explanation
Correct Answer
B:Measure whether intelligence-informed actions changed exposure or detection results. The scenario's unresolved need is control assurance, and this action produces monitoring evidence and accountable corrective actions for threat intelligence applicability. That directly addresses the risk that a highly publicized campaign may divert resources from threats actually relevant to local assets.
Incorrect Answers
A:Prioritize relevant monitoring, patching and risk treatment is pertinent to implementation, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for threat intelligence applicability.
C:Assign threat-intelligence decisions to an owner of critical assets is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for threat intelligence applicability.
D:Check whether adversary tactics and prerequisites apply to local assets is pertinent to risk evaluation, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for threat intelligence applicability.
Question 111
A payment processor says its controls make risk low, but nobody accepts accountability for the untreated and residual exposure. Which evidence should an independent reviewer seek to validate the current management decision?
- A signed exposure and control assessment informing the decision to estimate untreated exposure and independently verify control effectiveness.
- Deployment and representative operating tests demonstrating the decision to select further treatment where residual exposure exceeds approved tolerance was implemented.
- An approved responsibility and delegation record authorizing the decision to clarify inherent versus residual risk ownership and accountability.
- An assurance log of outcomes, exceptions and follow-up after the decision to retest the controls and obtain authorized acceptance of any residual risk.
Explanation
Correct Answer
C:An approved responsibility and delegation record authorizing the decision to clarify inherent versus residual risk ownership and accountability. It specifically verifies an approved decision and escalation record, the outstanding requirement in this case. This matters because untested provider controls cannot justify a reduction in the exposure accepted by the business and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
A:This demonstrates a later risk evaluation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
B:This demonstrates a later implementation objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
D:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved delegated ownership decision in the case. The evidence is valuable only when that prerequisite is met.
Question 112
A payment processor says its controls make risk low, but nobody accepts accountability for the untreated and residual exposure. Which decision addresses the documented deficiency most directly?
- Select further treatment where residual exposure exceeds approved tolerance.
- Retest the controls and obtain authorized acceptance of any residual risk.
- Estimate untreated exposure and independently verify control effectiveness.
- Clarify inherent versus residual risk ownership and accountability.
Explanation
Correct Answer
D:Clarify inherent versus residual risk ownership and accountability. The scenario's unresolved need is delegated ownership, and this action produces an approved decision and escalation record for residual risk measurement. That directly addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Select further treatment where residual exposure exceeds approved tolerance is pertinent to implementation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current residual risk measurement exposure unresolved, even if that later action is worthwhile.
B:Retest the controls and obtain authorized acceptance of any residual risk is pertinent to control assurance, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current residual risk measurement exposure unresolved, even if that later action is worthwhile.
C:Estimate untreated exposure and independently verify control effectiveness is pertinent to risk evaluation, but it depends on a still-missing delegated ownership decision or record. Applying it first would leave the current residual risk measurement exposure unresolved, even if that later action is worthwhile.
Question 113
A payment processor says its controls make risk low, but nobody accepts accountability for the untreated and residual exposure. A director recommends: "Estimate untreated exposure and independently verify control effectiveness." What response best addresses the evidence and decision authority in the case?
- Address the unmet requirement to clarify inherent versus residual risk ownership and accountability, while separately coordinating urgent protective steps within approved authority.
- Combine work to estimate untreated exposure and independently verify control effectiveness and select further treatment where residual exposure exceeds approved tolerance in a single funded milestone; document the decision to clarify inherent versus residual risk ownership and accountability for later closure.
- Authorize a bounded pilot to estimate untreated exposure and independently verify control effectiveness, then use its results to determine whether the team still needs to clarify inherent versus residual risk ownership and accountability.
- Begin with the alternative action to select further treatment where residual exposure exceeds approved tolerance and reassess whether the team still needs to clarify inherent versus residual risk ownership and accountability after observing outcomes.
Explanation
Correct Answer
A:This preserves the outstanding delegated ownership decision without treating estimate untreated exposure and independently verify control effectiveness as inherently invalid. The immediate requirement is an approved decision and escalation record. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
B:Bundling treatment activities can be efficient, but funding two other actions does not show the named delegated ownership gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to estimate untreated exposure and independently verify control effectiveness might be a useful pilot, but the case already identifies a missing delegated ownership requirement. A pilot cannot replace an approved decision and escalation record; it should be assessed only within authorized boundaries.
D:Select further treatment where residual exposure exceeds approved tolerance can be useful in residual risk measurement, but it does not eliminate the unmet requirement to clarify inherent versus residual risk ownership and accountability. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
Question 114
Control ownership is established, yet the processor has offered self-attestation without independent effectiveness evidence. The team proposes to estimate untreated exposure and independently verify control effectiveness. Who should authorize that decision within documented business and security limits?
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for residual risk measurement.
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to estimate untreated exposure and independently verify control effectiveness.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for residual risk measurement.
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for residual risk measurement.
Explanation
Correct Answer
B:For residual risk measurement, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for residual risk measurement. The responsible internal authority must approve consequential decisions.
C:Independent assurance should test and challenge the residual risk measurement decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.
D:Access to technical systems does not automatically confer enterprise authority over residual risk measurement. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
Question 115
Control ownership is established, yet the processor has offered self-attestation without independent effectiveness evidence. An updated assessment raises concern that untested provider controls cannot justify a reduction in the exposure accepted by the business. Which response keeps the management decision current and accountable?
- Report delivery of the existing residual risk measurement plan without reopening the previous risk assumptions.
- Continue the approved residual risk measurement exception until its original expiry, keeping the existing acceptance decision.
- Have the delegated risk owner reassess residual risk measurement and update the treatment decision to estimate untreated exposure and independently verify control effectiveness if new exposure exceeds tolerance.
- Let the delivery team revise the residual risk measurement response immediately and seek management ratification afterward.
Explanation
Correct Answer
C:Exposure and residual acceptance depend on current assumptions. A delegated owner must reassess the new evidence because untested provider controls cannot justify a reduction in the exposure accepted by the business. The evidence needed to estimate untreated exposure and independently verify control effectiveness should be documented and escalated when the risk exceeds approved tolerance.
Incorrect Answers
A:Historical approvals and task counts do not show that the changed risk remains within tolerance. The new condition warrants a refreshed analysis and accountable response, not solely activity reporting.
B:An exception record is not a substitute for assessing the significance of the new evidence to residual risk measurement. Earlier acceptance was conditional on facts that may no longer hold.
D:Urgent actions may be allowed within predelegated incident authority, but unilateral changes by implementers do not replace accountable reassessment and escalation when business impact changes.
Question 116
Testing found residual exposure above tolerance; the selected additional mitigation has not been applied. A director recommends: "Retest the controls and obtain authorized acceptance of any residual risk." What response best addresses the evidence and decision authority in the case?
- Begin with the alternative action to clarify inherent versus residual risk ownership and accountability and reassess whether the team still needs to select further treatment where residual exposure exceeds approved tolerance after observing outcomes.
- Combine work to retest the controls and obtain authorized acceptance of any residual risk and clarify inherent versus residual risk ownership and accountability in a single funded milestone; document the decision to select further treatment where residual exposure exceeds approved tolerance for later closure.
- Authorize a bounded pilot to retest the controls and obtain authorized acceptance of any residual risk, then use its results to determine whether the team still needs to select further treatment where residual exposure exceeds approved tolerance.
- Address the unmet requirement to select further treatment where residual exposure exceeds approved tolerance, while separately coordinating urgent protective steps within approved authority.
Explanation
Correct Answer
D:This preserves the outstanding implementation decision without treating retest the controls and obtain authorized acceptance of any residual risk as inherently invalid. The immediate requirement is an implemented and tested treatment. Any urgent safety or containment action can continue if it is authorized under a separate response plan.
Incorrect Answers
A:Clarify inherent versus residual risk ownership and accountability can be useful in residual risk measurement, but it does not eliminate the unmet requirement to select further treatment where residual exposure exceeds approved tolerance. The proposed order risks assessing the wrong outcome or missing accountable authorization for the case.
B:Bundling treatment activities can be efficient, but funding two other actions does not show the named implementation gap is resolved. The present management decision still needs a responsible owner and supporting evidence.
C:The proposal to retest the controls and obtain authorized acceptance of any residual risk might be a useful pilot, but the case already identifies a missing implementation requirement. A pilot cannot replace an implemented and tested treatment; it should be assessed only within authorized boundaries.
Question 117
Testing found residual exposure above tolerance; the selected additional mitigation has not been applied. What evidence would the risk committee need BEFORE it could close this finding?
- An accountable implementation sign-off and test result for the action to select further treatment where residual exposure exceeds approved tolerance.
- A control-performance review recording exceptions and corrections following work to retest the controls and obtain authorized acceptance of any residual risk.
- A version-controlled delegation and escalation memo establishing the authority to clarify inherent versus residual risk ownership and accountability.
- A risk treatment justification with service impact evidence supporting the decision to estimate untreated exposure and independently verify control effectiveness.
Explanation
Correct Answer
A:An accountable implementation sign-off and test result for the action to select further treatment where residual exposure exceeds approved tolerance. It specifically verifies an implemented and tested treatment, the outstanding requirement in this case. This matters because untested provider controls cannot justify a reduction in the exposure accepted by the business and an assertion of compliance alone cannot show that the risk has been managed.
Incorrect Answers
B:This demonstrates a later control assurance objective, but it cannot substitute for the unresolved implementation decision in the case. The evidence is valuable only when that prerequisite is met.
C:This would document earlier delegated ownership, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
D:This would document earlier risk evaluation, which the case has already established. It does not demonstrate an implemented and tested treatment required to resolve the current issue.
Question 118
Testing found residual exposure above tolerance; the selected additional mitigation has not been applied. What management gap should be addressed based on the evidence given?
- Reconfirm delegated approval to clarify inherent versus residual risk ownership and accountability.
- Put the approved plan into operation to select further treatment where residual exposure exceeds approved tolerance.
- Revisit assessed exposure to estimate untreated exposure and independently verify control effectiveness.
- Prepare an effectiveness review to retest the controls and obtain authorized acceptance of any residual risk.
Explanation
Correct Answer
B:Select further treatment where residual exposure exceeds approved tolerance. The scenario's unresolved need is implementation, and this action produces an implemented and tested treatment for residual risk measurement. That directly addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Clarify inherent versus residual risk ownership and accountability is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for residual risk measurement.
C:Estimate untreated exposure and independently verify control effectiveness is pertinent to risk evaluation, but the scenario already assumes that prerequisite is established. Repeating it does not provide an implemented and tested treatment now needed for residual risk measurement.
D:Retest the controls and obtain authorized acceptance of any residual risk is pertinent to control assurance, but it depends on a still-missing implementation decision or record. Applying it first would leave the current residual risk measurement exposure unresolved, even if that later action is worthwhile.
Question 119
Remediation is reported complete, but no retest confirms residual exposure within the agreed limits. The committee needs evidence about residual risk measurement. Which deliverable would address the identified deficiency most directly?
- A traceable deployment record and operating test confirming action to select further treatment where residual exposure exceeds approved tolerance for the operation needing effectiveness evidence.
- A signed delegation and escalation record authorizing the organization to clarify inherent versus residual risk ownership and accountability for the operation needing effectiveness evidence.
- An assurance review and corrective-action record confirming results from a decision to retest the controls and obtain authorized acceptance of any residual risk for the operation needing effectiveness evidence.
- A management-endorsed assessment documenting the evidence needed to estimate untreated exposure and independently verify control effectiveness for the operation needing effectiveness evidence.
Explanation
Correct Answer
C:Retest the controls and obtain authorized acceptance of any residual risk. The scenario's unresolved need is control assurance, and this action produces monitoring evidence and accountable corrective actions for residual risk measurement. That directly addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Select further treatment where residual exposure exceeds approved tolerance is pertinent to implementation, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for residual risk measurement.
B:Clarify inherent versus residual risk ownership and accountability is pertinent to delegated ownership, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for residual risk measurement.
D:Estimate untreated exposure and independently verify control effectiveness is pertinent to risk evaluation, but the scenario already assumes that prerequisite is established. Repeating it does not provide monitoring evidence and accountable corrective actions now needed for residual risk measurement.
Question 120
Remediation is reported complete, but no retest confirms residual exposure within the agreed limits. The team proposes to retest the controls and obtain authorized acceptance of any residual risk. Who should authorize that decision within documented business and security limits?
- The technical control operator because that role implements the approved configuration — using technical implementation responsibility as approval authority for residual risk measurement.
- The service provider because its contract covers the infrastructure — using contractual delivery responsibility as approval authority for residual risk measurement.
- The independent assurance reviewer who will later test the control — using independent review duties as approval authority for residual risk measurement.
- The accountable business or information owner acting within delegated limits and advised by security and affected functions — for the decision to retest the controls and obtain authorized acceptance of any residual risk.
Explanation
Correct Answer
D:For residual risk measurement, the named accountable authority can balance business, security and legal consequences under its delegated mandate. Specialist staff implement or advise; material deviations require escalation. The decision also addresses the risk that untested provider controls cannot justify a reduction in the exposure accepted by the business.
Incorrect Answers
A:Access to technical systems does not automatically confer enterprise authority over residual risk measurement. The operator may recommend or execute a properly authorized decision but cannot unilaterally accept the business consequences.
B:Contractual delivery responsibility and technical expertise do not transfer the enterprise’s ultimate accountability for residual risk measurement. The responsible internal authority must approve consequential decisions.
C:Independent assurance should test and challenge the residual risk measurement decision, not ordinarily authorize the activity it will later evaluate. That would blur accountability and separation of duties.